The angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury

Sven Asmussen, Eva Bartha, Gabor Olah, Elena Sbrana, Sebastian W. Rehberg, Yusuke Yamamoto, Perenlei Enkhbaatar, Hal K. Hawkins, Hiroshi Ito, Robert A. Cox, Lillian D. Traber, Daniel L. Traber, Csaba Szabo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We investigated the effect of the angiotensin-converting enzyme (ACE) inhibitor captopril in a clinically relevant ovine model of smoke and burn injury, with special reference to oxidative stress and activation of poly(ADP-ribose) polymerase, in the lung and in circulating leukocytes. Female, adult sheep (28-40 kg) were divided into three groups. After tracheostomy and under deep anesthesia, both vehicle-control-treated (n = 5) and captopril-treated (20 mg/kg per day, i.v., starting 0.5 h before the injury) (n = 5) groups were subjected to 2 × 20%, third-degree burn injury and were insufflated with 48 breaths of cotton smoke. A sham group not receiving burn/smoke was also studied (n = 5). Animals were mechanically ventilated and fluid resuscitated for 24 h in the awake state. Burn and smoke injury resulted in an upregulation of ACE in the lung, evidenced by immunohistochemical determination and Western blotting. Burn and smoke injury resulted in pulmonary dysfunction, as well as systemic hemodynamic alterations. Captopril treatment of burn and smoke animals improved PaO2/FiO2 ratio and pulmonary shunt fraction and reduced the degree of lung edema. There was a marked increase in PAR levels in circulating leukocytes after burn/smoke injury, which was significantly decreased by captopril. The pulmonary level of ACE and the elevated pulmonary levels of transforming growth factor β in response to burn and smoke injury were significantly decreased by captopril treatment. Our results suggest that the ACE inhibitor captopril exerts beneficial effects on the pulmonary function in burn/smoke injury. The effects of the ACE inhibitor may be related to the prevention of reactive oxygen species-induced poly(ADP-ribose)polymerase overactivation. Angiotensin-converting enzyme inhibition may also exert additional beneficial effects by inhibiting the expression of the profibrotic mediator transforming growth factor β.

Original languageEnglish (US)
Pages (from-to)402-409
Number of pages8
JournalShock
Volume36
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Ribose
Captopril
Angiotensin-Converting Enzyme Inhibitors
Smoke
Sheep
Lung
Wounds and Injuries
Peptidyl-Dipeptidase A
Burns
Poly(ADP-ribose) Polymerases
Transforming Growth Factors
Leukocytes
Tracheostomy
Reactive Oxygen Species
Edema
Oxidative Stress
Up-Regulation
Anesthesia
Hemodynamics
Western Blotting

Keywords

  • angiotensin
  • burn injury
  • cell death
  • lung
  • nitric oxide
  • nitrosative stress
  • oxidative stress
  • Smoke injury
  • vascular dysfunction

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine

Cite this

The angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury. / Asmussen, Sven; Bartha, Eva; Olah, Gabor; Sbrana, Elena; Rehberg, Sebastian W.; Yamamoto, Yusuke; Enkhbaatar, Perenlei; Hawkins, Hal K.; Ito, Hiroshi; Cox, Robert A.; Traber, Lillian D.; Traber, Daniel L.; Szabo, Csaba.

In: Shock, Vol. 36, No. 4, 10.2011, p. 402-409.

Research output: Contribution to journalArticle

Asmussen, Sven ; Bartha, Eva ; Olah, Gabor ; Sbrana, Elena ; Rehberg, Sebastian W. ; Yamamoto, Yusuke ; Enkhbaatar, Perenlei ; Hawkins, Hal K. ; Ito, Hiroshi ; Cox, Robert A. ; Traber, Lillian D. ; Traber, Daniel L. ; Szabo, Csaba. / The angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury. In: Shock. 2011 ; Vol. 36, No. 4. pp. 402-409.
@article{46990eca45474ded91822d984d00d7dc,
title = "The angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury",
abstract = "We investigated the effect of the angiotensin-converting enzyme (ACE) inhibitor captopril in a clinically relevant ovine model of smoke and burn injury, with special reference to oxidative stress and activation of poly(ADP-ribose) polymerase, in the lung and in circulating leukocytes. Female, adult sheep (28-40 kg) were divided into three groups. After tracheostomy and under deep anesthesia, both vehicle-control-treated (n = 5) and captopril-treated (20 mg/kg per day, i.v., starting 0.5 h before the injury) (n = 5) groups were subjected to 2 × 20{\%}, third-degree burn injury and were insufflated with 48 breaths of cotton smoke. A sham group not receiving burn/smoke was also studied (n = 5). Animals were mechanically ventilated and fluid resuscitated for 24 h in the awake state. Burn and smoke injury resulted in an upregulation of ACE in the lung, evidenced by immunohistochemical determination and Western blotting. Burn and smoke injury resulted in pulmonary dysfunction, as well as systemic hemodynamic alterations. Captopril treatment of burn and smoke animals improved PaO2/FiO2 ratio and pulmonary shunt fraction and reduced the degree of lung edema. There was a marked increase in PAR levels in circulating leukocytes after burn/smoke injury, which was significantly decreased by captopril. The pulmonary level of ACE and the elevated pulmonary levels of transforming growth factor β in response to burn and smoke injury were significantly decreased by captopril treatment. Our results suggest that the ACE inhibitor captopril exerts beneficial effects on the pulmonary function in burn/smoke injury. The effects of the ACE inhibitor may be related to the prevention of reactive oxygen species-induced poly(ADP-ribose)polymerase overactivation. Angiotensin-converting enzyme inhibition may also exert additional beneficial effects by inhibiting the expression of the profibrotic mediator transforming growth factor β.",
keywords = "angiotensin, burn injury, cell death, lung, nitric oxide, nitrosative stress, oxidative stress, Smoke injury, vascular dysfunction",
author = "Sven Asmussen and Eva Bartha and Gabor Olah and Elena Sbrana and Rehberg, {Sebastian W.} and Yusuke Yamamoto and Perenlei Enkhbaatar and Hawkins, {Hal K.} and Hiroshi Ito and Cox, {Robert A.} and Traber, {Lillian D.} and Traber, {Daniel L.} and Csaba Szabo",
year = "2011",
month = "10",
doi = "10.1097/SHK.0b013e318228f614",
language = "English (US)",
volume = "36",
pages = "402--409",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury

AU - Asmussen, Sven

AU - Bartha, Eva

AU - Olah, Gabor

AU - Sbrana, Elena

AU - Rehberg, Sebastian W.

AU - Yamamoto, Yusuke

AU - Enkhbaatar, Perenlei

AU - Hawkins, Hal K.

AU - Ito, Hiroshi

AU - Cox, Robert A.

AU - Traber, Lillian D.

AU - Traber, Daniel L.

AU - Szabo, Csaba

PY - 2011/10

Y1 - 2011/10

N2 - We investigated the effect of the angiotensin-converting enzyme (ACE) inhibitor captopril in a clinically relevant ovine model of smoke and burn injury, with special reference to oxidative stress and activation of poly(ADP-ribose) polymerase, in the lung and in circulating leukocytes. Female, adult sheep (28-40 kg) were divided into three groups. After tracheostomy and under deep anesthesia, both vehicle-control-treated (n = 5) and captopril-treated (20 mg/kg per day, i.v., starting 0.5 h before the injury) (n = 5) groups were subjected to 2 × 20%, third-degree burn injury and were insufflated with 48 breaths of cotton smoke. A sham group not receiving burn/smoke was also studied (n = 5). Animals were mechanically ventilated and fluid resuscitated for 24 h in the awake state. Burn and smoke injury resulted in an upregulation of ACE in the lung, evidenced by immunohistochemical determination and Western blotting. Burn and smoke injury resulted in pulmonary dysfunction, as well as systemic hemodynamic alterations. Captopril treatment of burn and smoke animals improved PaO2/FiO2 ratio and pulmonary shunt fraction and reduced the degree of lung edema. There was a marked increase in PAR levels in circulating leukocytes after burn/smoke injury, which was significantly decreased by captopril. The pulmonary level of ACE and the elevated pulmonary levels of transforming growth factor β in response to burn and smoke injury were significantly decreased by captopril treatment. Our results suggest that the ACE inhibitor captopril exerts beneficial effects on the pulmonary function in burn/smoke injury. The effects of the ACE inhibitor may be related to the prevention of reactive oxygen species-induced poly(ADP-ribose)polymerase overactivation. Angiotensin-converting enzyme inhibition may also exert additional beneficial effects by inhibiting the expression of the profibrotic mediator transforming growth factor β.

AB - We investigated the effect of the angiotensin-converting enzyme (ACE) inhibitor captopril in a clinically relevant ovine model of smoke and burn injury, with special reference to oxidative stress and activation of poly(ADP-ribose) polymerase, in the lung and in circulating leukocytes. Female, adult sheep (28-40 kg) were divided into three groups. After tracheostomy and under deep anesthesia, both vehicle-control-treated (n = 5) and captopril-treated (20 mg/kg per day, i.v., starting 0.5 h before the injury) (n = 5) groups were subjected to 2 × 20%, third-degree burn injury and were insufflated with 48 breaths of cotton smoke. A sham group not receiving burn/smoke was also studied (n = 5). Animals were mechanically ventilated and fluid resuscitated for 24 h in the awake state. Burn and smoke injury resulted in an upregulation of ACE in the lung, evidenced by immunohistochemical determination and Western blotting. Burn and smoke injury resulted in pulmonary dysfunction, as well as systemic hemodynamic alterations. Captopril treatment of burn and smoke animals improved PaO2/FiO2 ratio and pulmonary shunt fraction and reduced the degree of lung edema. There was a marked increase in PAR levels in circulating leukocytes after burn/smoke injury, which was significantly decreased by captopril. The pulmonary level of ACE and the elevated pulmonary levels of transforming growth factor β in response to burn and smoke injury were significantly decreased by captopril treatment. Our results suggest that the ACE inhibitor captopril exerts beneficial effects on the pulmonary function in burn/smoke injury. The effects of the ACE inhibitor may be related to the prevention of reactive oxygen species-induced poly(ADP-ribose)polymerase overactivation. Angiotensin-converting enzyme inhibition may also exert additional beneficial effects by inhibiting the expression of the profibrotic mediator transforming growth factor β.

KW - angiotensin

KW - burn injury

KW - cell death

KW - lung

KW - nitric oxide

KW - nitrosative stress

KW - oxidative stress

KW - Smoke injury

KW - vascular dysfunction

UR - http://www.scopus.com/inward/record.url?scp=80052962099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052962099&partnerID=8YFLogxK

U2 - 10.1097/SHK.0b013e318228f614

DO - 10.1097/SHK.0b013e318228f614

M3 - Article

C2 - 21701415

AN - SCOPUS:80052962099

VL - 36

SP - 402

EP - 409

JO - Shock

JF - Shock

SN - 1073-2322

IS - 4

ER -